The modest level of weight loss, approximately 5 %, may fall below thresholds typically associated with measurable bone loss, which could partly explain the neutral findings
Behavioural factors play an equally important role
the study physician attributed the death to pre-existing coronary artery disease unrelated to the drug, but the FDA's Pharmacy Compounding Advisory Committee cited this "unresolved cardiac signal" in December 2024 as a reason to keep the compound off the approved compounding list
Scientists dont know why semaglutide may have this protective effect
Common gastrointestinal effects include nausea (1520% of patients), vomiting, and early satiety, typically improving within weeks to months
C-reactive protein as an early predictor of COVID-19 severity